procaterol has been researched along with Transient Tachypnea of Newborn in 1 studies
Procaterol: A long-acting beta-2-adrenergic receptor agonist.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Taniguchi, A | 1 |
| Hayakawa, M | 1 |
| Matsusawa, M | 1 |
| Hayashi, S | 1 |
1 trial available for procaterol and Transient Tachypnea of Newborn
| Article | Year |
|---|---|
Inhaled procaterol for the treatment of transient tachypnea of the newborn.
Topics: Administration, Inhalation; Adrenergic beta-2 Receptor Agonists; Female; Humans; Infant, Newborn; In | 2018 |